Blog

Recap: citizen science

See this week’s handout here.

This week’s genomics salon, led by Orlando de Lange (blog, other blog, and  twitter), focused on citizen science. We opened with two main questions: what is citizen science, and why do citizen science? Orlando gave us a few working definitions to get started: citizen science is science that includes amateurs, and it encompasses public participation projects, community labs, and crowdfunding. From the professional scientists’ points of view, citizen science may help in data collection and analysis, fundraising, and education.

The “science” in citizen science
Early on, someone raised the issue of agency, or intentionality, a theme that stayed with us through the rest of the discussion. Many citizen science projects like Galaxy Zoo or SETI@home rely on very intentional public gathering or analysis of data. Others like Foldit or eBird incorporate a game-like, competitive aspect, and still others like TestMyBrain bring in citizen scientists themselves as subjects of research. In projects like Games With Purpose, games that serve primarily as entertainment can also be scientifically useful. These projects contrast dramatically with models in the social sciences – for instance, of community-driven forestry, in which a nonspecialist community is actively involved in ecological management. So how important is it that citizen scientists be actively and consciously engaged in research, and how much do current citizen-science projects fulfill these goals?

Testimonials
We got to hear from two actual practitioners of citizen science. Brian Koepnick, a graduate student in the Baker lab, talked about his experiences with Foldit, in which amateurs try to solve protein structures in a gamified environment. He told us about how Foldit players, who typically don’t have biochemistry backgrounds, could often come up with unusual and creative solutions to problems in protein design. Returning to the theme of individuality, we discussed how Foldit players are involved in hypothesis generation (that is, proposing different protein structures), requiring a degree of creativity not always seen in public participation projects.
Max Showalter, a graduate student in oceanology, told us about HiveBio, a local community biology lab. He gave the example of Citizen Salmon, a project in which amateur biologists test samples of salmon from local grocery stores and fish markets to find out where the fish originated. He also commented that community labs can be very different depending on their communities. Some are run mainly by professional scientists who enjoy working on projects in their spare time, and others may feature closer collaborations between scientists and artists. HiveBio runs mainly through classes and a membership model, providing basic equipment and training for community members of all ages to get involved with scientific projects. We discussed how the HiveBio model compares to outreach, and the degree to which community labs tend to play roles in research and education.

Citizen science and the future
We ended by discussing how citizen science might change traditional science. In fields like bioinformatics, competitions along the Kaggle model (for instance, those sponsored by the local nonprofit Sage Bionetworks) have already brought biological problems like cancer prediction to the attention of larger communities of programmers and data scientists. Several people raised concerns, however, about the lack of accountability or oversight on public projects, as well as the importance of expertise in interpreting complex biological datasets. In more equipment-intensive experimental biology fields, there was less optimism about whether citizen science would become a major player; it seems significant that most well-known citizen-science projects are in natural history and astronomy. As a final note, we returned to the term “citizen science” and the distinction it implies between scientist and citizen. There’s more work to be done, it seems, for the democratizing goals of citizen science to be fully realized.

Further resources
I wrote a long article on citizen science in my previous life as a science journalist, so at risk of shameless self-citation, that pretty well sums up most information I have on the subject – see here. That article ran with a(n arbitrary and incomplete) list of citizen scientist projects sampled from various fields – see here. For those in the Seattle area, the local HiveBio community lab is always looking for volunteers – email info@hivebio.edu to get involved.

Citizen Science Discussion with Dr. Orlando de Lange this Thursday!

Thursday, September 15, 4:30pm (Foege S-110)

Citizen Science

Orlando de Lange (Electrical Engineering)

For the past century, scientific research has primarily been conducted by highly trained individuals working in accredited institutions, but the internet and other technological changes have made it easier for non-specialists to be involved. This session will explore multiple models of public involvement in the daily practice of scientific research, ranging from citizen science to crowdfunding to DIYbio. What are the goals of citizen science, and how well do existing projects fulfill them? What new models remain to be explored?

Recap: dual-use research of concern

Influenza H5N1

Our discussion started by focusing on research studies on a strain of avian influenza (H5N1) that is highly pathogenic in humans, but apparently lacks the ability to efficiently transmit between humans. A concern is that increased human-to-human transmissibility could evolve in a natural setting, potentially resulting in a global pandemic. To investigate this concern, researchers evolved a new version of this strain in the lab that has acquired the ability to readily transmit between ferrets, a model organism for this type of work. In our discussion, the overall tone towards these studies was one of concern, with some people questioning whether they should have been done at all. Because there are devastating consequences to this strain being accidentally or intentionally released from a research lab (potentially seeding a global pandemic), the benefits of the research should outweigh the risks. But can we accurately evaluate the risks, given that the potential for human error or malfeasance is difficult to predict and the potential consequences so large? And aside from release from labs where this research is approved, what about the risk of other scientists or non-scientists synthesizing the genome of the strain themselves? The potential benefits were also called into question. Though the scientists who conducted the studies claim their findings will help inform surveillance efforts, many countries of interest apparently do not have good enough surveillance infrastructure to make this effective. And although these studies identified one way transmission could evolve in ferrets in the lab, there was doubt whether it would be likely to evolve the same way in humans in a natural setting.

Synthesizing a morphine precursor in yeast

We also discussed a recent study where the authors engineered a strain of yeast capable of synthesizing a precursor to morphine (http://science.sciencemag.org/content/349/6252/1095). Further development of this system could dramatically cuts down on the time and cost of production of the morphine precursor, making painkillers more available worldwide, but some have raised the concern it could be used in an unregulated way to produce illegal drugs (https://www.theguardian.com/science/2015/aug/13/yeast-cells-genetically-modified-to-create-morphine-like-painkiller).

What are actual examples where dual-use research has gone wrong?

The group brought up a few examples, including the 1977 influenza epidemic, the origin of which is unclear, but is thought to have arisen either from a misguided vaccine trail or a lab accident (http://mbio.asm.org/content/6/4/e01013-15.full). Another example was an outbreak of foot and mouth disease in England that may have resulted from accidental release from the lab (https://en.wikipedia.org/wiki/Foot-and-mouth_disease#United_Kingdom_2007)

Botulinum toxin

Our discussion also focused on the publication of a newly discovered botulinum toxin without a known antidote at the time of publication. We were surprised at the apparent lack of concern of government regulatory agencies about the potential for this toxin to be used in a harmful way. The lab that discovered the new toxin was more concerned and were reluctant to share the bacteria expressing this toxin with other labs, which ultimately identified an effective antidote. This topic lead us to the question…

Who should decide whether dual-use research should be conducted?

We agreed that we need to make this decision as a society, and that regulations should probably be enforced at multiple levels (e.g., awarding grants, publication of articles) since no level is perfect. Certain areas of dual-use research (e.g., fracking) are probably easier to control by standard governance than others (e.g., influenza transmissibility, geoengineering), the latter of which could have immediate irreversible impacts.

Genomics Salon Summary – 07/14 & 08/04

Thursday, July 14, 4:30pm (Foege S-110)
Jolie Carlisle (Genome Sciences) and Hugh Haddox (MCB)
Medicine is suffering from a “one-size-treat-all” treatment strategy. A desire for better treatment options has generated initiatives to develop medicines for demographic groups based on characteristics like race, sex, and age. This session will examine the pros and cons of such approaches and how culture has influenced the design of clinical trials. It will also examine the potential to use genetic information from individual patients to design personalized medical treatments: where has this approach been successful and what obstacles stand in its way?
Thursday, August 4, 4:30pm (Foege S-110)
Bioscience as change agent: rhetorics of restraint and inevitability in response to advances in genetic technologies
Leah Ceccarelli (Communication)
Last year, a group of scientists and bioethicists published an editorial in Science calling for a moratorium on the use of CRISPR-Cas9 for germline genome modification, drawing comparisons to the 1975 Asilomar letter calling for voluntary deferral of certain kinds of recombinant DNA research. This session will compare the rhetoric of these two influential statements. How does the language and framing of these two letters portray bioscience and its capacity for change? What do they suggest about our collective ability to shape the course of technological change?

Dual-Use Research of Concern

Just a reminder that there will be a salon discussion today at 4:30pm in S-110 on dual-use research of concern. Dr. Jesse Bloom and Andy Lin will be leading that discussion. Snacks and drinks will be provided. Hope you can join us!

To receive more information, subscribe to our Google group at
Thursday, August 18, 4:30pm (Foege S-110)
Dual-use research of concern
Andy Lin (Genome Sciences) and Jesse Bloom (Genome Sciences and Fred Hutch)

Biological research is frequently conducted with the goal of improving human welfare, but some experimental results have the potential to damage public health and safety through accidental or intentional misuse. In several recent cases, scientific institutions have placed limits on the publication or conduct of certain kinds of research. This session will examine the complications of such dual-use research of concern. How can scientists, policymakers, and the public assess the risks and benefits of potential lines of inquiry? Who ultimately decides what risks are worth taking?

Public Understanding of Science

Thank you so much for bringing your thoughts, experiences, and energy to the discussion today and for making our first salon session such a success. You can use this website to access discussion handouts and stay up to date with salon events.
We welcome any feedback on today’s discussion and suggestions for topics for future sessions! We are interested in exploring different discussion formats and topics and would love to know what you think. Just shoot me an email (ksxue@uw.edu) or leave a comment in our anonymous feedback box:  http://freesuggestionbox.com/pub/qeqaffq
We’re also looking for volunteers to lead discussions later in the summer, so also let one of us know if that’s a prospect that interests you. Don’t feel like you need to have a topic already in mind! The other organizers and I are happy to work with you to prepare for and structure a discussion on a topic that interests you.
As a final follow-up to today’s discussion, here’s are some media guides for scientists, developed based on surveys of science journalists:
Thanks again, and hope to see you on July 14 to discuss medicine and identity!
Your friendly salon organizers,
Katherine, Jolie, and Hugh
Here is the link for the 06/23/16 handout.

Welcome to the Genomics Salon!

Hi everyone,
We invite all of you to participate in a summer genomicssalon” to discuss social issues in genomics. The goal is to provide an informal forum for discussing subjects of general intellectual interest related to genomics and, more broadly, modern biology. The general idea comes from the Stanford AI salon, which gets students and faculty together every other week to discuss high-level issues related to artificial intelligence.
We would love to see you there! So far, we’ve set the following schedule for the first part of the summer, and we’ll add sessions in August and September based on interest and feedback. The format of each session will be a short, framing statement by the organizer following by free-form discussion. We’ll provide some snacks and drinks, and feel free to bring some of your own. We hope this will be light, fun, and interesting for everyone involved!
Thursday, June 24, 4:30pm (Foege S-110)
Public understanding of science
Katherine Xue (Genome Sciences) and Molly Gasperini (Genome Sciences)
Everyone agrees that science communication is important, but no one seems to agree how it should be done. Science communication–particularly science writing–is subject to criticism from multiple directions: for hype, for oversimplification, for inaccuracy, for uncritically taking scientists at their word. This session will explore the complications and contradictions of communicating science to the public. What do these criticisms suggest about how science communication is and should be done? What is it, really, that the public should know about science?
Thursday, July 14, 4:30pm (Foege S-110)
Medicine and identity
Jolie Carlisle (Genome Sciences) and Hugh Haddox (MCB)
Growing interest in personalized medicine has generated initiatives that aim to develop medicines for demographic groups based on characteristics like race and gender. This session will examine the complex ways in which medical science shapes ideas about identity at the level of both social groups (for instance, race and gender) and individuals (for instance, personality characteristics and mental health). How does science draw on and reinforce social concepts of identity? What are the implications for policy design?
Thursday, August 4, 4:30pm (Foege S-110)
Bioscience as change agent: rhetorics of restraint and inevitability in response to advances in genetic technologies
Leah Ceccarelli (Professor of Communication)
Last year, a group of scientists and bioethicists published an editorial in Science calling for a moratorium on the use of CRISPR-Cas9 for germline genome modification, drawing comparisons to the 1975 Asilomar letter calling for voluntary deferral of certain kinds of recombinant DNA research. This session will compare the rhetoric of these two influential statements. How does the language and framing of these two letters portray bioscience and its capacity for change? What do they suggest about our collective ability to shape the course of technological change?
Hope to see you there!
Your friendly genomics salon organizers,
Katherine, Jolie, and Hugh